The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients
This trial is active, not recruiting.
|Treatments||statin choice decision aid, control pamphlet|
|Sponsor||Mount Sinai School of Medicine|
|Start date||August 2007|
|End date||April 2010|
|Trial size||152 participants|
|Trial identifier||NCT00548639, 06-1415, ISRCTN12345678, NCI-793-0115D|
Diabetes is a growing epidemic within the United States that disproportionately affects economically disadvantaged communities like East Harlem. As diabetic patients are at very high risk for heart disease, experts recommend an aggressive approach towards using statins in people with diabetes. However, statins and other helpful drugs are only effective if patients decide to take them. Adherence to this medication is notoriously poor and is aggravated by its required life-long use. This study is designed to test the effectiveness of a new decision aid in helping diverse, inner-city patients with diabetes understand the risks and benefits in taking statins and whether this enhanced decision making process improves their adherence to the medication.
|Intervention model||parallel assignment|
|Masking||double blind (subject, investigator)|
Statin Choice Decision Aid
Morisky medication adherence scale
time frame: 3 months and 6 months
Male or female participants at least 21 years old.
Inclusion Criteria: - Diabetes Exclusion Criteria: - Not able to speak English or Spanish
|Official title||The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients|
|Principal investigator||Devin Mann, MD, MS|
Call for more information